MedTrace Logo

Comparison of IV Nalbuphine Versus Ibuprofen for Postoperative Pain Control in Cesarean Section

NCT06594224 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-09-19

No results posted yet for this study

Summary

The local data is insufficient to directly compare IV nalbuphine versus ibuprofen among people in this region. The findings of this study would add to the existing data and would be helpful for health providers to opt for a better option for postoperative pain relief following a cesarean section under general anesthesia.

Conditions

  • Pain Management

Interventions

DRUG

Ibuprofen

Patients were given 800 mg Ibuprofen in 200 cc normal saline intravenously at the time of arrival in the ward.

DRUG

Nalbuphine

Patients received 20 mg nalbuphine in 200 cc normal saline IV at the time of arrival in the ward.

Sponsors & Collaborators

  • Muhammad Aamir Latif

    lead OTHER

Principal Investigators

  • Mehnaz Khakwani, FCPS · Department of Obstetric and Gynecology Nishtar Medical University, Multan

  • Hajra Sultana, FCPS · Department of Obstetric and Gynecology Nishtar Medical University, Multan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2024-08-31
Completion
2024-08-31

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06594224 on ClinicalTrials.gov